Pulse Biosciences Inc (PLSE) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $53.09 (+4.90%), Market cap $1.82B, 52-week low–high $12.66 ~ $27.10.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and chan
Financial statements, price targets, institutional (13F) holdings and related news for Pulse Biosciences Inc are updated in real time on BlackAll Trade.
Pulse Biosciences Inc trades at $53.09 (+4.90%). Real-time quotes and charts are available on BlackAll Trade.
Pulse Biosciences Inc has a market cap of about $1.82B.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPuls